For Research Use Only. MOTS-c is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
AMPK and Inflammation Biology
The AMP activated protein kinase pathway has well documented anti-inflammatory effects that operate through multiple downstream mechanisms. AMPK activation suppresses NF-kB mediated pro-inflammatory gene expression, inhibits inflammasome activation, and modulates immune cell metabolism in ways that shift functional phenotypes toward less inflammatory profiles. The integrated AMPK anti-inflammatory biology is a well established area of research.
MOTS-c activates AMPK as documented in the MOTS-c AMPK article in this cluster. Through this central mechanism, MOTS-c engages the AMPK anti-inflammatory pathway in any tissue where AMPK activation occurs. The anti-inflammatory effects therefore operate across multiple tissue contexts and across multiple inflammatory research models.
The Nature subject hub on AMPK and the ScienceDirect AMPK signaling topic page archive primary research on AMPK anti-inflammatory biology.
Macrophage function is metabolically regulated. Pro-inflammatory M1 macrophages rely on glycolysis for rapid energy production. Anti-inflammatory M2 macrophages rely on oxidative phosphorylation with a more balanced metabolic profile. AMPK activation shifts macrophage metabolism toward the M2 profile with increased oxidative phosphorylation capacity, which supports the functional shift toward anti-inflammatory phenotype.
Published MOTS-c research on macrophage biology documents shifts toward M2 polarization, reduced pro-inflammatory cytokine production including tumor necrosis factor and interleukin 6, and enhanced anti-inflammatory cytokine production including interleukin 10. The macrophage effects integrate the mitochondrial and metabolic biology of MOTS-c with the functional immune biology of macrophage polarization.
The macrophage research connects to the VIP immune modulation article, the MT-1 anti-inflammatory article, and the Selank immunomodulation article. Multiple compounds address macrophage polarization through different mechanisms, and the MOTS-c approach through AMPK metabolic regulation is distinctive among these.
The Cell Press journal Cell Metabolism and the Wiley Online Library immunology collection archive primary research on macrophage metabolism and polarization.
NLRP3 Inflammasome Suppression
The NLRP3 inflammasome is a key inflammatory signaling complex that integrates metabolic and danger signals to produce interleukin 1 beta and interleukin 18 secretion. NLRP3 activation is implicated in many inflammatory diseases including metabolic syndrome, atherosclerosis, and neuroinflammatory conditions. Published MOTS-c research documents suppression of NLRP3 inflammasome activation through AMPK mediated pathways.
The NLRP3 suppression provides a mechanistic link between the metabolic improvements of MOTS-c administration and the anti-inflammatory effects. Metabolic stress activates NLRP3 signaling, and reducing metabolic stress reduces inflammasome activation. The AMPK activation directly suppresses inflammasome assembly in addition to the indirect metabolic effects.
The inflammasome research connects to the broader anti-inflammatory research across adjacent clusters. The mechanistic specificity of NLRP3 suppression makes MOTS-c research relevant to the specific inflammatory contexts where NLRP3 is a central driver of pathology.
Circulating Inflammatory Markers
Published MOTS-c research documents reductions in circulating inflammatory markers in obese, diabetic, and aged rodent models. C reactive protein, interleukin 6, tumor necrosis factor, and monocyte chemoattractant protein 1 are all reduced under MOTS-c treatment. The reductions reflect both direct immune cell effects and indirect effects through the metabolic improvements that reduce the inflammatory inputs from visceral adipose tissue and other inflammatory sources.
The circulating marker data provides an integrated measure of systemic inflammatory tone that complements the tissue specific endpoints. The reductions occur progressively over treatment periods of weeks to months, consistent with the time course of the body composition improvements documented in the MOTS-c obesity article.
Tissue Specific Inflammation
Different tissues have different inflammatory biology and different MOTS-c responses. In adipose tissue, MOTS-c reduces macrophage infiltration and shifts the adipose inflammatory profile toward less inflammatory patterns. In liver, MOTS-c reduces hepatic inflammatory cell accumulation and reduces hepatic inflammatory gene expression. In skeletal muscle, MOTS-c supports the exercise induced anti-inflammatory environment. In brain, MOTS-c reduces neuroinflammatory markers as part of the neuroprotective profile.
The tissue specific inflammation research provides mechanistic detail on how the systemic anti-inflammatory effects manifest across different organ systems. The pattern is consistent with broad AMPK activation producing anti-inflammatory effects wherever AMPK activation can reach.
The tissue inflammation research connects to the GLP-2 TZ inflammation article and the BPC-157 cytoprotection article which cover tissue inflammation from different pharmacological perspectives.
Aging and Inflammaging
Chronic low grade inflammation that accumulates with age, termed inflammaging, contributes to the decline in tissue function and resilience that characterizes aging biology. Published MOTS-c research in aged models documents attenuated inflammaging markers with preserved tissue function. The inflammaging reduction complements the direct aging effects documented in the MOTS-c aging article.
The aging inflammation research connects to the NAD+ in Research: A Comprehensive Review of Nicotinamide Adenine Dinucleotide Studies and the glutathione immune article. Multiple compounds address the intersection of aging biology and inflammation through different mechanisms, and the MOTS-c contribution operates through mitochondrial and AMPK pathways.
The Frontiers in Aging open access journal archives primary research on inflammaging.